Cargando…
Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result
INTRODUCTION: Interim analysis of phase I and phase II clinical trials of personalized vaccines made from autologous monocyte-derived dendritic cells (DCs) incubated with S-protein of SARS-CoV-2 show that this vaccine is safe and well tolerated. Our previous report also indicates that this vaccine c...
Autores principales: | Jonny, Jonny, Putranto, Terawan Agus, Yana, Martina Lily, Sitepu, Enda Cindylosa, Irfon, Raoulian, Ramadhani, Bunga Pinandhita, Sofro, Muchlis Achsan Udji, Nency, Yetty Movieta, Lestari, Endang Sri, Triwardhani, Ria, Mujahidah, Sari, Retty Karisma, Soetojo, Nur Alaydrus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315914/ https://www.ncbi.nlm.nih.gov/pubmed/37404828 http://dx.doi.org/10.3389/fimmu.2023.1122389 |
Ejemplares similares
-
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
por: Jonny, Jonny, et al.
Publicado: (2022) -
Significant improvement of systemic lupus erythematosus manifestation in children after autologous dendritic cell transfer: a case report and review of literature
por: Jonny, et al.
Publicado: (2023) -
A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses
por: Nistor, Gabriel I., et al.
Publicado: (2022) -
A Case-Control Study of the MTHFR C665T Gene Polymorphism on Macrocytic Anemia Among HIV-Infected Patients Receiving Zidovudine
por: Pertiwi, Danis, et al.
Publicado: (2022) -
Peritoneal Dialysis Patient Training Program to Enhance independence and Prevent Complications: A Scoping Review
por: Jaelani, Toni Rahmat, et al.
Publicado: (2023)